Bibliografia

 

1. Pellegrino R et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26(5):948-68.
2. 2016 Global Initiative for Chronic Obstructive Lung Disease.
3. Schluchter et al. Classifying Severity of Cystic Fibrosis Lung Disease Using Longitudinal Pulmonary Function Data. Am J Respir Crit Care Med 2006; 174(780-786).
4. McNulty et al. Techniques of assessing small airways dysfunction. European Clinical Respiratory Journal 2014; 1:25898.
5. Elkins MR et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med. 2006; 354(3):229-40.
6. Wark P et al. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001506. doi: 10.1002/14651858.CD001506.pub3.
7. Cazzarolli C et al. The Advantages of Adding Hyaluronic Acid or Mannitol to Hypertonic Saline Inhalation Treatment in Cystic Fibrosis. J Aerosol Med Pulm Drug Deliv. 2016 Aug 26. [Epub ahead of print]
8. Turino GM et al. Hyaluronan in respiratory injury and repair. Am J Respir Crit Care Med. 2003; 167(9):1169-75.
9. Venge P et al. Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis. Am J Respir Crit Care Med. 1996; 153(1):312-6.
10. Petrigni G et al. Aerosolised hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma. Pulm Pharmacol Ther. 2006; 19(3):166-71.
11. Ros M et al. Hyaluronic Acid Improves the Tolerability of Hypertonic Saline in the Chronic Treatment of Cystic Fibrosis Patients: A Multicenter, Randomized, Controlled Clinical Trial. J Aerosol Med Pulm Drug Deliv. 2014; 27(2):133-7.
12. Pradal U et al. Hyaluronic acid in the prevention of bronchial obstruction induced by hypertonic saline. Journal of Cystic Fibrosis 2010; Vol. 9, S62.
13. Gavina M et al. Nebulized Hyaluronan Ameliorates lung inflammation in cystic fibrosis mice. Pediatric Pulmonology 2013; 48(8):761-771.
14. Lamas A et al. Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease. Respiratory Research 2016; 17(1):123.

 

 

<< Torna alla Home